Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RST
4301
DELISTED
ROSETTA STONE INC
RST
| $687K | ﹤0.01% |
40,714
+19,197
| +89% | +$323K |
|
|
TDAY
4302
USA Today Co
TDAY
$1.32B
| $686K | ﹤0.01% |
496,791
+23,399
| +5% | +$30.8K |
|
4303
Mistras Group
MG
$507M
| $686K | ﹤0.01% |
173,936
+166,212
| +2,152% | +$688K |
|
|
CUTR
4304
DELISTED
Cutera, Inc.
CUTR
| $686K | ﹤0.01% |
56,452
-5,107
| -8% | -$67.3K |
|
|
BRY
4305
DELISTED
Berry Corp
BRY
| $684K | ﹤0.01% |
141,622
+67,790
| +92% | +$262K |
|
4306
TriMas Corp
TRS
$1.45B
| $683K | ﹤0.01% |
28,548
-32,026
| -53% | -$736K |
|
4307
NN Inc
NNBR
$297M
| $682K | ﹤0.01% |
143,981
-169,142
| -54% | -$591K |
|
4308
Capitol Federal Financial
CFFN
$1.13B
| $681K | ﹤0.01% |
61,820
+34,528
| +127% | +$396K |
|
|
CXH
4309
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $680K | ﹤0.01% |
72,042
-33,295
| -32% | -$303K |
|
4310
Daily Journal
DJCO
$827M
| $679K | ﹤0.01% |
2,512
+751
| +43% | +$200K |
|
4311
Mercantile Bank Corp
MBWM
$1.07B
| $679K | ﹤0.01% |
30,078
-704
| -2% | -$15.5K |
|
|
FWP
4312
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $679K | ﹤0.01% |
110,499
+62,605
| +131% | +$399K |
|
|
AZEK
4313
DELISTED
The AZEK Co
AZEK
| $677K | ﹤0.01% |
+21,246
| New | +$646K |
|
4314
PAR Technology
PAR
$719M
| $674K | ﹤0.01% |
22,520
+9,566
| +74% | +$209K |
|
|
NJV
4315
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
| $674K | ﹤0.01% |
53,822
-1,693
| -3% | -$21.3K |
|
4316
Saratoga Investment
SAR
$322M
| $673K | ﹤0.01% |
42,568
-2,090
| -5% | -$30.8K |
|
4317
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$39.4M
| $671K | ﹤0.01% |
27,396
-14,901
| -35% | -$344K |
|
|
CSCI
4318
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $671K | ﹤0.01% |
8,371
-204
| -2% | -$18.7K |
|
4319
Cooper-Standard Automotive
CPS
$546M
| $670K | ﹤0.01% |
50,581
-4,783
| -9% | -$58K |
|
4320
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.1M
| $670K | ﹤0.01% |
26,492
-32,030
| -55% | -$765K |
|
4321
Quince Therapeutics
QNCX
$26.8M
| $668K | ﹤0.01% |
72
+20
| +38% | +$183K |
|
|
THS
4322
DELISTED
Treehouse Foods
THS
| $668K | ﹤0.01% |
15,244
-4,699
| -24% | -$229K |
|
|
TURN
4323
DELISTED
180 Degree Capital
TURN
| $666K | ﹤0.01% |
127,575
-248
| -0.2% | -$1.16K |
|
4324
Aspen Aerogels
ASPN
$419M
| $665K | ﹤0.01% |
101,097
+38,825
| +62% | +$249K |
|
4325
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$368M
| $665K | ﹤0.01% |
17,045
-15,502
| -48% | -$556K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.